Found 15 matching trials
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation PHASE1 The purpose of this study is to investigate the safety and feasibility of g...
Show More Location
Columbia University Irving Medical Center/NYP
Learn More & Join Trial
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant NA This clinical trial studies how well donor stem cell boost works in treatin...
Show More Location
Multiple Locations
Learn More & Join Trial
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant NA Patients in need of an allogeneic hematopoietic cell transplant (HCT) are a...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies PHASE2 The purpose of this study is compare the efficacy of haplo-cord transplant ...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation PHASE2 In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders NA This is a study to evaluate the safety and efficacy of Miltenyi CliniMACS® ...
Show More Location
University of Colorado
Learn More & Join Trial
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant NA The CliniMACS® device is FDA-approved only for one indication (CD34+ select...
Show More Location
Multiple Locations
Learn More & Join Trial
Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies PHASE2 This research study is studying the removal of a subset of white blood cell...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Autologous Gene Therapy for Artemis-Deficient SCID PHASE1 This study aims to determine if a new method can be used to treat Artemis-d...
Show More Location
University of California, San Francisco (UCSF) Children's Hospital
Learn More & Join Trial
CliniMACS® CD34+ Reagent System for Expanded Access Use N/A CliniMACs is an investigational device used to select and enrich stem cells...
Show More Status
No Longer Available
Location
Dana Farber Cancer Institute
Learn More & Join Trial